ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,084, issued on June 17, was assigned to Valneva Austria GmbH (Vienna).
"Multivalent OspA polypeptides and methods and uses relating thereto" was invented by Urban Lundberg (Pressbaum, Austria), Andreas Meinke (Pressbaum, Austria), Abhijeet Nayak (Amsterdam) and Wolfgang Schuler (Vienna).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an immunogenic polypeptide, a nucleic acid encoding the same, a pharmaceutical composition comprising the same and the immunogenic polypeptide, nucleic acid or pharmaceutical composition for use as a medicament, particularly a vaccine, or for use in a method of treating or preventing a Bor...